These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38992854)
1. Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma. Claesson HE; Sjöberg J; Xu D; Björkholm M Prostaglandins Other Lipid Mediat; 2024 Oct; 174():106871. PubMed ID: 38992854 [TBL] [Abstract][Full Text] [Related]
2. Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling. Horn T; Adel S; Schumann R; Sur S; Kakularam KR; Polamarasetty A; Redanna P; Kuhn H; Heydeck D Prog Lipid Res; 2015 Jan; 57():13-39. PubMed ID: 25435097 [TBL] [Abstract][Full Text] [Related]
3. Janus kinase deregulation in leukemia and lymphoma. Chen E; Staudt LM; Green AR Immunity; 2012 Apr; 36(4):529-41. PubMed ID: 22520846 [TBL] [Abstract][Full Text] [Related]
4. Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat nephron. Reinhold SW; Vitzthum H; Filbeck T; Wolf K; Lattas C; Riegger GA; Kurtz A; Krämer BK Am J Physiol Renal Physiol; 2006 Apr; 290(4):F864-72. PubMed ID: 16219916 [TBL] [Abstract][Full Text] [Related]
5. FGF-2 expression and its action in human leukemia and lymphoma cell lines. Krejci P; Faitova J; Laurell H; Hampl A; Dvorak P Leukemia; 2003 Apr; 17(4):818-20. PubMed ID: 12682649 [No Abstract] [Full Text] [Related]
6. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892 [TBL] [Abstract][Full Text] [Related]
7. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Haeggström JZ; Funk CD Chem Rev; 2011 Oct; 111(10):5866-98. PubMed ID: 21936577 [No Abstract] [Full Text] [Related]
8. Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. Schain F; Schain D; Mahshid Y; Liu C; Porwit A; Xu D; Claesson HE; Sundström C; Björkholm M; Sjöberg J Clin Lymphoma Myeloma; 2008 Dec; 8(6):340-7. PubMed ID: 19064398 [TBL] [Abstract][Full Text] [Related]
9. Lessons to be learned from hematopoietic malignancies. Workshop report from the Division of Research Grants, National Institutes of Health. Matrisian LM; Tykocinski ML; Padarathsingh M Am J Pathol; 1995 Nov; 147(5):1519-21. PubMed ID: 7485414 [No Abstract] [Full Text] [Related]
10. ETS1 Function in Leukemia and Lymphoma. Luchtel RA Adv Exp Med Biol; 2024; 1459():359-378. PubMed ID: 39017852 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of the MDM2 oncogene in leukemia and lymphoma. Watanabe T; Ichikawa A; Saito H; Hotta T Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803 [TBL] [Abstract][Full Text] [Related]
13. Human bronchial fibroblasts express the 5-lipoxygenase pathway. James AJ; Penrose JF; Cazaly AM; Holgate ST; Sampson AP Respir Res; 2006 Jul; 7(1):102. PubMed ID: 16872537 [TBL] [Abstract][Full Text] [Related]
15. The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders. Jo-Watanabe A; Okuno T; Yokomizo T Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336653 [TBL] [Abstract][Full Text] [Related]
16. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092 [TBL] [Abstract][Full Text] [Related]
17. Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines. Tahir SK; Wass J; Joseph MK; Devanarayan V; Hessler P; Zhang H; Elmore SW; Kroeger PE; Tse C; Rosenberg SH; Anderson MG Mol Cancer Ther; 2010 Mar; 9(3):545-57. PubMed ID: 20179162 [TBL] [Abstract][Full Text] [Related]
18. Genetics and pharmacogenetics of the leukotriene pathway. Tantisira KG; Drazen JM J Allergy Clin Immunol; 2009 Sep; 124(3):422-7. PubMed ID: 19665766 [TBL] [Abstract][Full Text] [Related]
19. Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines. Ayyub Khan M; Tateson JE; Hoffbrand AV; Wickremasinghe RG Leuk Res; 1993 Mar; 17(3):241-5. PubMed ID: 8450672 [TBL] [Abstract][Full Text] [Related]
20. Targeting neuropilin-1 in human leukemia and lymphoma. Karjalainen K; Jaalouk DE; Bueso-Ramos CE; Zurita AJ; Kuniyasu A; Eckhardt BL; Marini FC; Lichtiger B; O'Brien S; Kantarjian HM; Cortes JE; Koivunen E; Arap W; Pasqualini R Blood; 2011 Jan; 117(3):920-7. PubMed ID: 21063027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]